Search research articles
Contact Us
Filters
Showing results (81-90 of 297) with videos related to
Page
of 30
Sort By:
Ejhaem
|
August 21, 2023
SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731
Caitlin W Elgarten, John A Kairalla, Joel C Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2020
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Sumit Gupta, Cindy Wang, Elizabeth A Raetz, et al.
Cancer Research
|
March 14, 2019
Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia
Ernesto Diaz-Flores, Evan Q Comeaux, Kailyn L Kim, et al.
Blood Advances
|
October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 study
Luke Maese, Mignon L Loh, Mi Rim Choi, et al.
British Journal of Haematology
|
July 20, 2016
Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemia
Rachel E Rau, Andrew J Carroll, Nyla A Heerema, et al.
Cancer
|
November 8, 2017
Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial
Daniel J Zheng, Xiaomin Lu, Reuven J Schore, et al.
Blood
|
April 27, 2013
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia
Shilpa Gandre-Babbe, Prasuna Paluru, Chiaka Aribeana, et al.
Haematologica
|
January 30, 2025
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children's Oncology Group AALL1231 trial
Margot S F Roeten, Johan Van Meerloo, Suzanne N Van Dijk, et al.
JCO Precision Oncology
|
November 9, 2023
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay
Elliot Stieglitz, Christine J Gu, Michelle Richardson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2017
Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group
Kristina K Hardy, Leanne Embry, John A Kairalla, et al.
Page
of 30
Search research articles
Search
Showing results (81-90 of 297) with videos related to
Sort By:
Page
of 30
Ejhaem
|
August 21, 2023
SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731
Caitlin W Elgarten, John A Kairalla, Joel C Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2020
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Sumit Gupta, Cindy Wang, Elizabeth A Raetz, et al.
Cancer Research
|
March 14, 2019
Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia
Ernesto Diaz-Flores, Evan Q Comeaux, Kailyn L Kim, et al.
Blood Advances
|
October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 study
Luke Maese, Mignon L Loh, Mi Rim Choi, et al.
British Journal of Haematology
|
July 20, 2016
Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemia
Rachel E Rau, Andrew J Carroll, Nyla A Heerema, et al.
Cancer
|
November 8, 2017
Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial
Daniel J Zheng, Xiaomin Lu, Reuven J Schore, et al.
Blood
|
April 27, 2013
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia
Shilpa Gandre-Babbe, Prasuna Paluru, Chiaka Aribeana, et al.
Haematologica
|
January 30, 2025
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children's Oncology Group AALL1231 trial
Margot S F Roeten, Johan Van Meerloo, Suzanne N Van Dijk, et al.
JCO Precision Oncology
|
November 9, 2023
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay
Elliot Stieglitz, Christine J Gu, Michelle Richardson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2017
Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group
Kristina K Hardy, Leanne Embry, John A Kairalla, et al.
Page
of 30